US Broker Ratings

Clover Health Investments (CLOV): Analyzing a 60% Potential Upside with a Focus on Revenue Growth

Clover Health Investments, Corp. (NASDAQ: CLOV) stands out in the healthcare sector with a compelling narrative that combines robust revenue growth with significant potential upside. This Wilmington, Delaware-based company offers..

Kestra Medical Technologies (KMTS) Stock Analysis: Unpacking the 65% Potential Upside

For investors keen on the healthcare sector, Kestra Medical Technologies, Ltd. (NASDAQ: KMTS) presents a compelling opportunity with its significant potential upside of 65.17%. Headquartered in Kirkland, Washington, Kestra is..

Apellis Pharmaceuticals (APLS) Stock Analysis: Exploring a 93% Potential Upside in the Biotech Sector

Apellis Pharmaceuticals, Inc. (NASDAQ: APLS) stands out in the biotechnology industry with a compelling narrative for investors seeking opportunities in healthcare innovation. With a market capitalization of $2.3 billion, Apellis..

Arcutis Biotherapeutics, Inc. (ARQT) Stock Analysis: Exploring a 57.78% Potential Upside for Investors

Arcutis Biotherapeutics, Inc. (NASDAQ: ARQT) is capturing the attention of investors with a remarkable potential upside of 57.78%, according to the latest analyst ratings. As a biotechnology firm focused on..

Adaptive Biotechnologies (ADPT) Stock Analysis: Navigating a 10.14% Upside Potential

Adaptive Biotechnologies Corporation (NASDAQ: ADPT), a prominent player in the biotechnology industry, is capturing investor attention with its innovative approach to immune medicine and a promising upside potential of 10.14%...

Select Medical Holdings Corp (SEM) Stock Analysis: Exploring a 34.78% Potential Upside

Select Medical Holdings Corporation (NYSE: SEM) presents an intriguing opportunity for investors with its robust presence in the healthcare sector, particularly within the medical care facilities industry. With a market..

LeMaitre Vascular, Inc. (LMAT) Stock Analysis: Exploring a 27% Potential Upside in the Healthcare Sector

LeMaitre Vascular, Inc. (NASDAQ: LMAT), a prominent player in the medical instruments and supplies industry, presents an intriguing opportunity for investors seeking exposure to the healthcare sector. Headquartered in Burlington,..

SS Innovations International (SSII) Stock Analysis: A High-Growth Healthcare Opportunity in Surgical Robotics

In the rapidly evolving field of medical devices, SS Innovations International Inc. (SSII) stands out as a pioneering player in surgical robotics. Headquartered in Gurugram, India, and operating internationally, the..

CONMED Corporation (CNMD) Stock Analysis: Exploring a 24.77% Potential Upside in the Medical Devices Sector

CONMED Corporation (NASDAQ: CNMD) is a prominent player in the healthcare sector, specifically within the medical devices industry. With a market capitalization of $1.65 billion, this U.S.-based company has established..

Veracyte, Inc. (VCYT): Investor Outlook with 53% Potential Upside

Veracyte, Inc. (NASDAQ: VCYT) stands as a dynamic player in the healthcare sector, specializing in diagnostics and research. Headquartered in South San Francisco, California, Veracyte has established a robust presence..

Bausch Health Companies Inc. (BHC) Stock Analysis: A 19.85% Upside Awaits Investors Amidst Market Challenges

Bausch Health Companies Inc. (NYSE: BHC), a prominent player in the healthcare sector, has long been a subject of interest for investors looking to tap into the dynamic world of..

Certara, Inc. (CERT) Stock Analysis: A Healthcare Innovator with 46% Upside Potential

Certara, Inc. (NASDAQ: CERT), a leader in healthcare’s health information services sector, presents an intriguing opportunity for investors seeking exposure to the niche market of biosimulation technology. With a current..

Concentra Group Holdings Parent (CON): Analyst Consensus Signals 31% Upside Potential

For investors seeking promising opportunities in the healthcare sector, Concentra Group Holdings Parent, Inc. (CON) stands out with a compelling growth narrative. Positioned in the medical care facilities industry, Concentra..

Ardent Health, Inc. (ARDT) Stock Analysis: Exploring a Promising 57% Upside Potential

Ardent Health, Inc. (ARDT), a prominent player in the U.S. healthcare sector, is gaining attention from investors due to its promising growth metrics and analyst endorsements. Based in Brentwood, Tennessee,..

Indivior PLC (INDV) Investor Outlook: Understanding the Growth Potential in a Critical Healthcare Sector

Indivior PLC (INDV), a key player in the healthcare sector, focuses on addressing the critical challenge of opioid dependence through its range of buprenorphine-based prescription drugs. With a market capitalization..

BGM Group Ltd. (BGM) Stock Analysis: Navigating Uncharted Waters with a 52-Week High Surge

BGM Group Ltd. (BGM) is a Chinese healthcare entity that has carved a niche in the drug manufacturing sector, focusing on both specialty and generic pharmaceuticals. The company’s stock has..

Kymera Therapeutics, Inc. (KYMR) Stock Analysis: A Biotech Powerhouse with 33% Potential Upside

Kymera Therapeutics, Inc. (NASDAQ: KYMR) is making waves in the biotech sector with its innovative approach to treating serious diseases by leveraging the body’s natural protein degradation system. As a..

Perrigo Company plc (PRGO) Stock Analysis: Exploring a 36.76% Potential Upside in Healthcare

Perrigo Company plc (NYSE: PRGO), a prominent player in the healthcare sector, is offering intriguing opportunities for investors with a potential upside of 36.76%, according to analyst price targets. Headquartered..

AtriCure, Inc. (ATRC) Investor Outlook: Analyzing the 54% Potential Upside Amid Strong Buy Ratings

AtriCure, Inc. (NASDAQ: ATRC) is garnering attention from investors with its robust growth potential in the healthcare sector, specifically within the medical instruments and supplies industry. Despite the current challenging..

Centessa Pharmaceuticals (CNTA) Investor Outlook: Exploring a 150% Potential Upside

Centessa Pharmaceuticals plc (NASDAQ: CNTA) is commanding attention in the biotechnology sector with a compelling narrative that could entice savvy investors. As a clinical-stage pharmaceutical company headquartered in Altrincham, United..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds